European Urology Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.5 | Q1 | 94.8% | 3.010 | Q1 | 97.7% |
| 2024 | 9.3 | Q1 | 95.5% | 3.419 | Q1 | 98.2% |
| 2023 | 8.3 | Q1 | 93.7% | 2.719 | Q1 | 97.4% |
| 2022 | 8.2 | Q1 | 94.4% | 2.597 | Q1 | 97.3% |
| 2021 | 8.2 | Q1 | 94.1% | 2.299 | Q1 | 96.8% |
| 2020 | — | — | 3.107 | Q1 | 98.0% | |
| 2019 | — | — | 1.475 | Q1 | 92.4% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2588-9311
country
NLcoverage
2018-2026